Advertising regulator clears ‘dead rat’ cinema ad

May 11, 2009
Sales and Marketing counterfeits

Pfizer's hard-hitting advert about the dangers of using counterfeit medicines did not breach advertising regulations, according to the Advertising Standards …

Allergan closes doors on Irish plant

May 8, 2009
Manufacturing and Production Allergan

US drugmaker Allergan has brought the curtain down on its manufacturing facility in Arklow, Ireland, months ahead of schedule. The …

Pharma must go further with its collaborations

May 8, 2009
Research and Development, Sales and Marketing pwC, strategy

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …

Servier signs drug discovery deal with Vernalis

May 7, 2009
Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …

NICE rejects Nexavar for liver cancer

May 7, 2009
Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …

Avastin approved for aggressive brain tumour

May 7, 2009
Sales and Marketing GBM, avastin

 Roche has gained US approval for Avastin in people with the aggressive brain cancer glioblastoma multiforme (GBM). The drug can …

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009
Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …

NHS should be ‘jewel in the crown’ for UK biotech

May 7, 2009
Research and Development NICE

The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …

Sanofi-Aventis makes 200m euro push into antibodies

May 7, 2009
Manufacturing and Production Sanofi-Aventis, biologicals

Sanofi-Aventis will spend 200 million euros to convert one of its facilities near Paris into a biotechnology facility which is …

Building better relations with tomorrow’s doctors

May 6, 2009
Sales and Marketing doctors, industry relations

A huge amount of time and money is spent by the pharma industry on interacting with the medical community and …

Bayer launches UK television ads for its morning-after pill

May 6, 2009
Sales and Marketing Bayer

Bayer Schering Pharma has launched a television advertising campaign for its morning-after pill Levonelle One Step in the UK. The …

Pharma manufacturing: news in brief

May 6, 2009
Manufacturing and Production Pfizer

Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including Pfizer's increased adoption of contract manufacturing and facility …

Ranbaxy woes continue with antibiotic recall

May 6, 2009
Sales and Marketing Ranbaxy, US

Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …

Bayer Schering’s contraceptive patch enters phase III

May 5, 2009
Research and Development, Sales and Marketing Bayer, sexual health

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …

EDQM takes issue with more Chinese APIs

May 5, 2009
Manufacturing and Production Asia, China

The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …

Coast first casualty in US overhaul of IRB system

May 5, 2009
Research and Development FDA, US

A US company offering institutional review board services to sponsors of clinical trials has been forced to close its doors …

Pfizer dips in first quarter

May 1, 2009
Sales and Marketing Pfizer

Pfizer saw its performance dip in the first quarter of 2009, with revenue down 8% year-on-year. The company, which is …

Biotech partnering in the credit crunch

May 1, 2009
Research and Development biotech, partnering, pharma

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …

BMS turns in solid first quarter results

May 1, 2009
Sales and Marketing BMS

Bristol-Myers Squibb turned in respectable figures for the first quarter of 2008, with net income up 5% to $921 million. …

The Gateway to Local Adoption Series

Latest content